ConductScience.org, home

Paper31347149

Pharmacology of bisphosphonates in pain.

Tzschentke TM. Br J Pharmacol, 2021. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Pharmacology of bisphosphonates in pain. Papers, record 31347149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31347149

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacology of bisphosphonates in pain.
PubMed
Journal
Br J Pharmacol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
2.25
iCite
Revised in PubMed
2021-07-05
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tzschentke TMThomas Mhttps://orcid.org/0000-0002-7270-1522

Source PubMed

Download CSV of authors

Topics3

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Chronic PainMajor topic
DiphosphonatesMajor topic
Animals

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
42491984Zoledronic acid produces analgesia by inhibiting the transient receptor potential vanilloid 1 (TRPV1) channel.Pain Rep2026https://conductscience.org/library/papers/42491984PubMed
41737302Intravenous Pamidronate in Persistent Complex Regional Pain Syndrome (CRPS): A Retrospective Observational Study on Effectiveness and Tolerability.J Pain Res2026https://conductscience.org/library/papers/41737302PubMed
41599114Pharmacological Management of Cancer Pain: Advances in Treatment Strategies and Drug Delivery Systems.Pharmaceutics2025https://conductscience.org/library/papers/41599114PubMed
41341143Comparative Effects of Minodronate and Alendronate on Low Back Pain in Postmenopausal Osteoporosis and Age Influence: A Head-to-Head, Randomized Clinical Trial.Clin Interv Aging2025https://conductscience.org/library/papers/41341143PubMed
40634658Pain in Osteoporosis: Current and Future Strategies.Drugs Aging2025https://conductscience.org/library/papers/40634658PubMed
40372122Transient osteoporosis of the hip and fatty liver disease: Case report and pathogenic hypothesis.J Int Med Res2025https://conductscience.org/library/papers/40372122PubMed
39323655Pamidronate for pain in adult chronic nonbacterial osteitis: protocol of a randomized, double-blind, placebo-controlled trial.JBMR Plus2024https://conductscience.org/library/papers/39323655PubMed
3925732510. Complex regional pain syndrome.Pain Pract2025https://conductscience.org/library/papers/39257325PubMed
38799611The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs.Ther Adv Musculoskelet Dis2024https://conductscience.org/library/papers/38799611PubMed
38627292Neuropathic and Nociplastic Pain Profiles are Common in Adult Chronic Nonbacterial Osteitis (CNO).Calcif Tissue Int2024https://conductscience.org/library/papers/38627292PubMed
38626145Clodronate disodium does not produce measurable effects on bone metabolism in an exercising, juvenile, large animal model.PLoS One2024https://conductscience.org/library/papers/38626145PubMed
38585006Comparison of the relative diagnostic performance of 68Ga-DOTA-IBA and 18F-NaF for the detection of bone metastasis.Front Oncol2024https://conductscience.org/library/papers/38585006PubMed
36569491Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study.Ther Adv Musculoskelet Dis2022https://conductscience.org/library/papers/36569491PubMed
35370739Bisphosphonates Targeting Ion Channels and Musculoskeletal Effects.Front Pharmacol2022https://conductscience.org/library/papers/35370739PubMed
35247200From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome.Drugs2022https://conductscience.org/library/papers/35247200PubMed
34924556Antibody-induced pain-like behavior and bone erosion: links to subclinical inflammation, osteoclast activity, and acid-sensing ion channel 3-dependent sensitization.Pain2022https://conductscience.org/library/papers/34924556PubMed
34881273Does Bisphosphonate Increase the Sclerosis of Tibial Subchondral Bone in the Progression of Knee Osteoarthritis-A Propensity Score Matching Cohort Study Based on Osteoarthritis Initiative.Front Med (Lausanne)2021https://conductscience.org/library/papers/34881273PubMed
34215993Bisphosphonates, Bone and Joint Pain.Curr Osteoporos Rep2021https://conductscience.org/library/papers/34215993PubMed
33799992The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis.Int J Mol Sci2021https://conductscience.org/library/papers/33799992PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31347149

GET https://conductscience.org/api/papers/v1/31347149/authors